Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Aptevo Therapeutics Inc. buy melinda

Start price
€3.81
12.03.20 / 50%
Target price
€16.80
04.11.21
Performance (%)
243.49%
End price
€13.08
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €13.08. With a performance of 243.49% the BUY prediction by melinda was a big success. melinda has 50% into this prediction

Unfortunately, there is no listed company called Aptevo Therapeutics with the symbol APVOV. However, there is a company with the symbol APVO. Aptevo Therapeutics is a biotechnology company that focuses on the discovery, development, and commercialization of novel oncology and hematology therapeutics. The company's product portfolio includes treatments for a variety of conditions such as hemophilia, immune disorders, and cancer. Their approach involves using genetically engineered proteins to target specific diseases and their therapies have shown promising results in clinical trials.

Performance without dividends (%)
Name 1w 1m 1y 3y
Aptevo Therapeutics Inc. - - - -
iShares Core DAX® 2.149% 5.415% 21.385% 22.595%
iShares Nasdaq 100 0.838% 1.926% 44.386% 55.330%
iShares Nikkei 225® 1.143% 2.887% 27.641% 9.481%
iShares S&P 500 1.265% 3.698% 33.327% 49.646%

Comments by melinda for this prediction

In the thread Aptevo Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 243.49%
Target price 1.200
Change
Ends at 04.11.21

Buy mit Kursziel 1,2

In the thread Trading Aptevo Therapeutics Inc.
Prediction Buy
Perf. (%) 243.49%
Target price 16.800
Change
Ends at 04.11.21

Die von melinda gewählte maximale Laufzeit wurde überschritten

Stopped prediction by melinda for Aptevo Therapeutics Inc.

buy
Aptevo Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.09
31.01.23
€3.00
31.01.24
-9.32%
14.02.23